Integrative modeling of eQTLs and cis-regulatory elements suggest
  mechanisms underlying cell type specificity of eQTLs by Brown, Christopher D et al.
1Integrative modeling of eQTLs and cis-regulatory elements
suggest mechanisms underlying cell type specificity of eQTLs
Christopher D Brown1,2∗, Lara M Mangravite3, Barbara E Engelhardt1,4∗
1 Department of Human Genetics, University of Chicago, Chicago, IL, USA
2 Institute for Genomic and Systems Biology, University of Chicago, Chicago, IL, USA
3 Sage Bionetworks, Seattle, WA, USA
4 Currently at: Biostatistics & Bioinformatics Department and Institute for Genome
Sciences & Policy, Duke University, Durham, NC, USA
∗ E-mail: caseybrown@uchicago.edu, barbara.engelhardt@duke.edu
Abstract
Genetic variants in cis-regulatory elements or trans-acting regulators commonly influence the quantity
and spatiotemporal distribution of gene transcription. Recent interest in expression quantitative trait
locus (eQTL) mapping has paralleled the adoption of genome-wide association studies (GWAS ) for the
analysis of complex traits and disease in humans. Under the hypothesis that many GWAS associations
tag non-coding SNPs with small effects, and that these SNPs exert phenotypic control by modifying
gene expression, it has become common to interpret GWAS associations using eQTL data. To fully
exploit the mechanistic interpretability of eQTL-GWAS comparisons, an improved understanding of the
genetic architecture and cell type specificity of eQTLs is required. We address this need by performing
an eQTL analysis in four parts: first we identified eQTLs from eleven studies on seven cell types; next we
quantified cell type specific eQTLs across the studies; then we integrated eQTL data with cis-regulatory
element (CRE ) data sets from the ENCODE project; finally we built a classifier to predict cell type
specific eQTLs. Consistent with prior studies, we demonstrate that allelic heterogeneity is pervasive at
cis-eQTLs and that cis-eQTLs are often cell type specific. Within and between cell type eQTL replication
is associated with eQTL SNP overlap with hundreds of cell type specific CRE element classes, including
enhancer, promoter, and repressive chromatin marks, regions of open chromatin, and many classes of
DNA binding proteins. These associations provide insight into the molecular mechanisms generating
the cell type specificity of eQTLs and the mode of regulation of corresponding eQTLs. Using a random
forest classifier including 526 CRE data sets as features, we successfully predict the cell type specificity of
eQTL SNPs in the absence of gene expression data from the cell type of interest. We anticipate that such
integrative, predictive modeling will improve our ability to understand the mechanistic basis of human
complex phenotypic variation.
Introduction
The precise spatial and temporal control of gene transcription is critical for biological processes, as evi-
denced by the causal role of gene expression perturbation in many human diseases [1–3]. Gene expression
is controlled by regulatory proteins, RNAs, and the cis-regulatory elements with which they interact.
Genetic variation within cis-regulatory elements (CREs, e.g., transcription promoters, enhancers, or in-
sulators) can affect gene expression in a cell type specific manner. An extensive body of work, performed
in a variety of cell types in both humans and model organisms, has demonstrated that genetic variants that
impact gene expression, or expression quantitative trait loci (eQTLs), are common and exist in both cis
(local) and trans (over long genetic distances) [3–6]. Over 85% of genotype-phenotype associations iden-
tified in genome-wide association studies (GWAS ) are with non-coding single nucleotide polymorphisms
(SNPs), making their mechanistic interpretation more challenging. It is possible that these associated
SNPs tag for coding SNPs; however, numerous compelling lines of evidence [2, 7–11] demonstrate that
regulatory SNPs have causal roles in many complex human phenotypes. This is further supported by the
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2finding that GWAS associations are enriched within DNase hypersensitivity (DHS ) sites [12] and eQTL
SNPs [13, 14], and by several elegant GWAS follow up studies that have mechanistically tied disease
associations with SNPs that cause the misregulation of gene expression [15,16].
Although eQTLs are increasingly used to provide mechanistic interpretations for human disease asso-
ciations, the cell type specificity of eQTLs presents a problem. Because the cell type from which a given
physiological phenotype arises may not be known, and because eQTL data exist for a limited number of
cell types, it is critical to quantify and understand the mechanisms generating cell type specific eQTLs.
For example, if a GWAS identifies a set of SNPs associated with risk of type II diabeties, the researcher
must choose a target cell type to develop a mechanistic model of the molecular phenotype that causes
the gross physiological change. One can imagine that the relevant cell type might be adipose tissue, liver,
pancreas, or another hormone-regulating tissue. Furthermore, if the GWAS SNP produces a molecular
phenotype (i.e., is an eQTL) in lymphoblastoid cell lines (LCLs), it is not necessarily the case that the
SNP will generate a similar molecular phenotype in the cell type of interest. Furthermore, there are many
examples of cell types with particular relevance to common diseases, for example dopaminergic neurons
and Parkinson’s disease, that lack comprehensive eQTL data or catalogs of CREs. The utility of eQTLs
for complex trait interpretation will therefore be improved by a more thorough annotation of their cell
type specificity. While several studies have quantified the reproducibility of eQTLs within or between
cell types derived from the same or different individuals [17–27] the determinants of eQTL cell specificity
are still largely unknown.
In this study, we analyzed eQTL data collected from eleven studies performed in seven different
cell types. We used Bayesian regression models to identify all cis-linked SNPs that are independently
associated with each gene expression trait in each study. We find that accurately evaluating the frequency
of overlap between eQTLs in distinct cell types is heavily dependent on confounding factors intrinsic to
all eQTL studies. The typical eQTL overlap frequency between independent studies of the same cell
type reaches ≈ 80%, and thus, assuming that true eQTLs within a cell type should always replicate
across studies, eQTLs that do not replicate between cell types will show up as drops from this lower
bound rather than from an idealized 100%. Moreover, eQTL replication frequencies are not uniformly
distributed but are instead sensitive to numerous technical and biological covariates. For example, given
that within cell type eQTL replication is dependent on the distance between the SNP and the TSS [26],
simultaneous analysis of within and between cell type eQTL replication is necessary to characterize the
relationship between eQTL cell type specificity and SNP location. Therefore, a biologically meaningful
definition of eQTL cell type specificity requires us to identify, quantify, and properly control for factors
that influence replication within cell types.
In an effort to functionally interpret the associations tagged by eQTL SNPs, we quantified the inter-
actions between eQTL SNPs and 526 CRE data sets, many of which were derived from the cell types
used in eQTL discovery and are known to function in a cell type specific manner (e.g., transcription
factor binding sites (TFBSs), open chromatin regions (OCRs)). We further considered the relationship
between eQTL SNP-CRE overlap and the cell type specificity of eQTL replication. Lastly, we built a
random forest classifier to predict the cell type specificity of eQTLs in the absence of additional gene
expression data. We believe this predictive model will facilitate more substantial functional analyses of
GWAS results by enabling the integration of disease genetics with the thousands of genomic data sets
that have been produced by projects like ENCODE [28,29].
Results
A uniform analysis of cis-eQTLs across seven cell types
In an effort to comprehensively characterize eQTL reproducibility within and between different cell types,
we gathered publicly available data sets that included both gene expression and genotype data. This
3collection included eleven studies from seven unique cell types (Table 1) [17, 26, 30–32]. To ensure the
data from each eQTL study were comparable, we uniformly processed all raw data by developing a
standardized analysis pipeline that was designed to marginalize the effect of study design differences on
the identified eQTLs (see Methods). Genotype data, regardless of array type, were subjected to standard
quality control filters. Missing and unobserved genotypes were subsequently imputed to the SNPs in the
HapMap phase 2 CEPH panel (3, 907, 239 SNPs) using BIMBAM [33, 34]. Each gene expression array
was uniformly re-annotated; probe sequences were aligned to the human reference genome (hg18) and
to RefSeq gene models. Within each array platform, multiple probes mapping to a single gene were
clustered as in previous work [26]. Only uniquely aligned probes that did not overlap known, common
polymorphisms were included in our analysis.
Table 1. Study Information. The Accession numbers are from the GEO database when
prefixed with GSE and from the Synapse database when prefixed with syn. Study label is
the name used to refer to the study throughout the paper. TLA is the three letter
acronym used to reference the study in figures. CAP stands for the Cholesterol and
Pharmacogenetics Trial [35, 36].
Study label TLA Tissue N N genes PMID Accession Platform Genotype
CAP LCL CPL LCLs 480 18718 20339536 GSE36868 GPL6883-5509 ILMN 310K & ILMN QUAD
Stranger LCL STL LCLs 210 15752 17289997 GSE6536 GPL2507 NA
Harvard cerebellum HCE Cerebellum 540 18263 NA syn4505 GPL4372 GPL14932
Harvard prefrontal cortex HPC Prefrontal cortex 678 18257 NA syn4505 GPL4372 GPL14932
Harvard visual cortex HVC Visual cortex 463 18263 NA syn4505 GPL4372 GPL14932
GenCord fibroblast GCF blood fibroblasts 83 16691 19644074 GSE17080 GPL6884 GPL6982
GenCord LCL GCL LCLs 85 16691 19644074 GSE17080 GPL6884 GPL6982
GenCord tcell GCT blood t cells 85 16691 19644074 GSE17080 GPL6884 GPL6982
UChicago liver CLI Liver 206 16236 21637794 GSE26106 GPL4133 GPL8887
Merck liver MLI Liver 266 18234 18462017 GSE9588 GPL4372 GPL3720&GPL3718&GPL6987
Myers brain MBR Brain 193 11707 17982457 GSE8919 GPL2700 GPL3720&GPL3718
Given the non-uniform collection and availability of covariate information across studies (e.g., sample
age, sex, array batch), we chose to control for the confounding effects of both known covariates and
unknown factors by removing the effects of principal components (PCs; Table S1) [37,38]. We projected
residual expression variation to the quantiles of a standard normal distribution to control for outliers,
and used these projected values as the quantitative traits for association mapping, which was performed
in each study set using the same HapMap phase 2 CEPH SNP panel. We evaluated evidence for gene
expression-genotype associations in terms of Bayes factors (BFs) using BIMBAM [33, 39], as BFs have
been shown to be more robust to SNPs with small minor allele frequencies (MAF ) than p-values [33,40].
Although we computed a BF for every SNP-gene pair, we limit our subsequent analysis to cis-linked
SNPs, or SNPs within 1Mb of the transcription start site (TSS ) or transcription end site (TES ) of
a gene. False discovery rates (FDRs) for each study were empirically estimated by permutation. All
comparisons between studies were performed on expressed gene-SNP pairs common to both studies. See
Methods for complete details on the data preparation and association mapping.
Considering only the most highly associated cis-SNP for each RefSeq gene (the primary eQTL SNP),
across the studies considered here, we observe between 585 and 5433 genes with eQTLs (FDR ≤ 5%),
corresponding to log10BF thresholds between 2.70 and 3.86 (Figures 1A-C, Table 2). As expected, studies
with larger sample sizes (p < 3.95× 10−6) and replicate gene expression measurements (p < 1.58× 10−4)
identified more eQTLs at a given FDR threshold (Figure 1D). Indeed, across the 11 studies examined
here, > 95% of the variance in the proportion of genes with eQTLs can be explained by sample size and
expression replication. The effect size distribution relative to study and to log10BF is also consistent with
the expectation that larger studies identify eQTLs with smaller effect sizes (Figures S1-2). We expect
that future eQTL studies with larger sample sizes (even from previously examined cell types) will identify
additional eQTLs with smaller effects. We find that, despite study heterogeneity, the relationship between
BF and FDR is quite uniform across studies (Figure 1A). As demonstrated in previous studies [41, 42],
4eQTL SNPs are highly enriched at the transcription start site (TSS ) and transcription end site (TES )
of the associated gene (Figure 1F).
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Figure 1. Descriptive statistics of cis-eQTLs and allelic heterogeneity across studies.
Studies are labeled by their acronym from Table 1. (A) Plot of log10 FDR (y-axis) as a function of
log10BF (x-axis), for each study as a separate line of a diferent color, as indicated in panels B, D, and
E. Dashed line represents FDR ≤ 5%. (B) Plot of log10 eQTL counts as function of log10BF , for all
studies. (C) eQTL count (x-axis) by tier, for tiers 1-4 (light blue, dark blue, light green, and dark green,
respectively), with separate bars for each study (y-axis). (D) Fraction of genes with a significant eQTL
SNP (y-axis; thresholded at FDR ≤ 5%), as function of sample size (x-axis). Each study is plotted in a
distinct color, as indicated with labels. Studies with replicate expression measurements are depicted as
triangles, studies without as circles. (E) Fraction of genes with a significant eQTL that have more than
one independently associated SNP (y-axis; thresholded at FDR ≤ 5%), as a function of sample size
(x-axis). Each study is plotted in a distinct color. Studies with replicate expression measurements are
depicted as triangles, studies without as circles. (F) Histogram of eQTL counts by tier (y-axis; colors as
in panel C), summed across studies, as a function of their distance to the gene transcription start and
end sites (x-axis; gene split into 10 bins). P (grey) line depicts the counts of first tier eQTL SNPs from
a permutation, to illustrate the background distribution of tested SNPs.
Alellic heterogeneity is a pervasive property of cis-eQTLs
The extent to which multiple co-localized genetic variants exert independent influence on human phe-
notypes, referred to as allelic heterogeneity, is largely unknown. Several recent GWAS meta-analyses
5Table 2. Study-specific cis-eQTLs and log10BF cutoff values for 1%, 5%, 10%, and 20%
FDRs. The cutoff values for each FDR were determined via permutation; see Methods for
details.
FDR 1% 1% 5% 5% 10% 10% 20% 20%
Study Tissue log10BF eQTLs log10BF eQTLs log10BF eQTLs log10BF eQTLs
GenCord fibroblasts 3.16 566 3.58 772 2.35 916 1.99 1292
GenCord t cells 3.40 450 2.85 596 2.47 749 2.07 1076
GenCord LCLs 3.37 441 2.72 649 2.46 782 2.06 1111
Harvard cerebellum 3.18 3367 2.59 4065 2.29 4595 1.95 5547
Harvard prefrontal cortex 3.21 4331 2.51 5189 2.24 5775 1.88 6833
Harvard visual cortex 3.24 2872 2.63 3469 2.29 4095 1.96 5040
Merck liver 3.52 2333 2.90 2828 2.55 3272 2.21 4078
Myers brain 3.17 688 2.61 888 2.30 1076 1.99 1408
UChicago liver 3.29 1951 2.60 2543 2.25 3005 1.93 3687
Stranger LCLs 3.32 3147 2.67 3759 2.37 4167 2.06 4695
CAP LCLs 3.09 5094 2.42 5810 2.14 6335 1.82 7235
have estimated the frequency of allelic heterogeneity underlying human genotype-phenotype associa-
tions [43, 44], however, the number of associations examined remains relatively small. For example,
19 of 180 loci significantly associated with human height have more than one independently associated
SNP [43].
Given that transcription for each gene is regulated by a complex interplay of multiple regulatory
elements, often over large distances, it is plausible, and indeed expected, that numerous segregating
cis-SNPs may independently affect the expression of a single gene. In particular, the ENCODE project
has identified millions of regulatory elements across most of the genome, and these elements impact the
transcription of only ∼ 23, 000 genes [28, 29]. Recently, several studies have quantified the frequency
of allelic heterogeneity underlying eQTLs [45, 46], with estimates ranging from 9 − 54%. We sought to
extend these observations by leveraging the unprecedented size and breadth of the current combined
study to identify the set of cis-SNPs that are independently associated with expression levels of each
gene and to quantify the frequency of allelic heterogeneity in gene regulation (see Methods). To do this,
we first identified, for each gene probe cluster, the most highly associated SNP within each local linkage
disequilibrium (LD) block, tested the independence of each SNP by multivariate regression (Figure S3),
and took the union of the independent SNPs that regulate a single gene. We refer to, for example,
the first and second most significant, independently associated SNPs as primary and secondary SNPs,
respectively, and we refer to the set of primary (secondary) SNPs as the primary (secondary) tier. For
each study, and within each tier, we independently estimated FDR by permutation.
Across all eleven studies, 29% (3225 of 11081) of eQTL-regulated RefSeq genes are independently
associated with at least two SNPs in at least one study (FDR ≤ 5%; Figures 1C and 1E, Figures S1-2).
Within each study, the fraction of eQTL-regulated genes with two or more independently associated SNPs
ranges from 3− 22% (FDR ≤ 5%). As with primary eQTL discovery, sample size (p < 4.34× 10−6) and
replicate expression measurements (p < 8.63× 10−4) are significantly and independently associated with
the fraction of eQTL loci exhibiting significant allelic heterogeneity. Our search for allelic heterogeneity
is power-limited and our estimates of its frequency should be taken as a lower bound; larger sample
sizes will identify additional heterogeneity. Second tier eQTL SNPs reside significantly further from the
associated gene TSS than primary tier eQTL SNPs (Figure 1D). For example, in the CAP LCL eQTL
data set, the median absolute distances between the TSS and primary and secondary eQTL SNPs are 64
6and 165 kb, respectively (p < 2.2× 10−16).
We performed a Gene Ontology (GO) [47] enrichment analysis (Table S2), which did not reveal easily
interpretable functional differences in eQTL-regulated gene sets by cell type or tier. This implies that
there are no obvious functional differences between either genes with more than one eQTL SNP, genes
with a single eQTL SNP, and the background set of tested genes, further supporting the hypothesis that
most genes harbor one or more eQTL SNPs of small effect, but power and computational limitations
preclude identification of the complete set.
To determine the accuracy of our LD-based approximate method, we performed forward stepwise
regression (FSR) on subset of genes with allelic heterogeneity [48, 49]. We compared the results from
these two models on a set of 696 genes with allelic heterogeneity in the CAP LCL study (i.e., at least
secondary eQTL SNPs; FDR ≤ 5%). Our LD-based allelic heterogeneity ascertainment generally appears
to underestimate the number of independently associated SNPs per gene, however this may be a result
of the thresholds for SNP inclusion between the two methods being different (Figure S4, Table S3).
Cis-eQTL replication within and between cell types
We next investigated the cell type specificity of eQTLs, comparing eQTLs identified both within and
between cell types. Cell type specific eQTLs are defined here as eQTL SNPs that replicate across studies
of the same cell type but fail to replicate across studies of different cell types. Given the broad array
of technical and biological factors known to influence the reproducibility of eQTLs [21, 22, 26, 37], our
analysis of eQTL replication focused on three specific comparison sets:
1. CAP LCL versus Stranger LCL and Merck liver
2. UChicago liver versus Merck liver and Stranger LCL
3. Harvard cerebellum versus Myers brain and Stranger LCL.
Each trio of comparisons enabled the simultaneous quantification of within and between cell type eQTL
reproducibility. Each of the six studies above used different expression platforms and were composed
entirely of independent samples; principled approaches for the analysis of platform specific effects and
paired subject study designs are the subject of current research. We note that this specific selection of
comparisons is somewhat arbitrary but was driven by the computational requirements of each comparison
and the sample size of the discovery cohort. However, the conclusions highlighted below are largely
independent of the particular discovery cohort, replication cohort, or cell type (Figure 2, Figure S5,
Table S4). We note that the Myers brain samples include samples from several different brain cell types,
a minority of which were cerebellum, implying that the cell type matching in comparison 3 above is
inexact.
Consistent with previous observations, we find that a meaningful fraction of cis-eQTLs are cell type
specific (Figure 2, Figures S5-7). Gene Ontology (GO) [47] enrichment analysis (Table S2) did did not
reveal readily interpretable functional differences between sets of ubiquitous or cell type specific eQTLs.
Across all comparisons, we find that within cell type replication frequencies, as a function of log10BF ,
plateau at ≈ 80%, while between cell type replication frequencies plateau at ≈ 60% (Figures 2A-C). Cis-
eQTLs are therefore significantly more likely to replicate across studies within the same cell type than they
are to replicate between different cell types (e.g., in CAP LCL: p < 2.2 × 10−16). We found that eQTL
replication frequency is significantly associated with a number of factors (quantified by Equation (2)).
Within and between cell type replication of CAP LCL eQTLs is positively associated with discovery
significance (within: p < 2.2×10−16, between: p < 1.78×10−11) and negatively associated with absolute
distance to the TSS (within: p < 2.2 × 10−16, between: p < 2.94 × 10−6) and with eQTL tier (within:
p < 2.49×10−11, between: p < 4.06×10−11). We find that as the level of discovery significance increases,
the likelihood that the eQTL replicates in both matched and unmatched cell types also increases, implying
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Figure 2. Cell type specific eQTL replication frequencies. (A, B, C) eQTL replication
frequency (y-axis) as a function of discovery significance (x-axis;log10BF ). SNPs were grouped into 30
equally spaced bins by BF. (D, E, F) eQTL replication frequency (y-axis; thresholded at 5%FDR) as a
function of SNP position (|SNP− TSS|) (x-axis). Cis-eQTL SNPs within 250kb of the TSS were
grouped into 30 equally spaced bins. (A, D) Replication frequencies for CAP LCL eQTLs in
Stranger LCLs (blue) and Merck liver (red). (B, E) Replication frequencies for UChicago liver eQTLs
in Merck liver (blue) and Stranger LCL (red). (C, F) Replication frequencies for Myers brain eQTLs in
Harvard cerebellum (blue) and Stranger LCL (red). In all panels, bold lines depict percentage of
SNP-gene pairs with log10BF ≥ 1 per bin, and ribbons depict 95% confidence interval.
that cell type specific eQTLs tend to have smaller effects (Figure S7). Comparing each discovery data set
with permuted replication data produced very few replicated associations, implying that the proportion of
false positive replications is likely to be small (results not shown). However, we suspect that eQTLs that
fail to replicate within cell type primarily consist of false negative replications, with a small proportion
due to false positive eQTLs in the discovery data set that would not be expected to replicate in the
second study. Comparing the proportion eQTLs that replicated between cell types to the proportion of
eQTLs that replicated both within and between cell types may approximate the within cell type false
negative rate under these assumptions (Figure S7).
Previous reports have conflicted with regards to the relationship between cell type specificity and
eQTL location [17, 18, 24]. Our simultaneous analysis of within and between cell type replication across
multiple discovery cell types sheds some light on this conflict: distal eQTLs are inherently less reproducible
than are promoter proximal eQTLs, even across studies of the same cell type (Figure 2D-F). Without
controlling for this effect, it would appear that between cell type replication frequencies decrease with
increasing distance from the TSS (Figure 2D-F, Figures S6-7). Indeed, within cell type replication
actually decreases at a modestly faster rate than does between cell type replication frequency (Figure
2D-F; p < 4.38 × 10−9, 0.152, 1.90 × 10−4, for LCLs, liver, and brain, respectively). In addition, cell
specific replication frequency peaks at the TSS and decreases modestly at more distally linked SNPs
(Figure S7). Any differences between the spatial distributions of cell type specific and more ubiquitous
eQTLs therefore appear to be quite subtle.
eQTL SNP tier is significantly associated with eQTL replication frequencies; primary tier eQTL
SNPs are significantly more reproducible than additional independently associated SNPs (Figure S8). For
example, primary and secondary CAP LCL eQTL SNPs (FDR ≤ 5%) exhibit within cell type replication
8frequencies of 56.2% and 25.1%, respectively (Fisher’s exact test p < 2.2× 10−16). Additionally, primary
eQTL SNPs are significantly less likely to be cell type specific, relative to additional independently
associated SNPs. For example, 63.4% and 73.0% of primary and secondary CAP LCL eQTL SNPs are
cell type specific, respectively (Fisher’s exact test p < 1.23 × 10−5). Therefore, for any given gene, the
most highly associated eQTL SNP is more likely to be TSS-proximal, of large effect, and observed in
additional cell types, whereas additional independent eQTL SNPs are more likely to be specific to the
discovery cell type, have smaller effect sizes, and reside further from the TSS.
eQTL SNPs are associated with many classes of cis-regulatory elements
We next sought to investigate the biological characteristics associated with the reproducibility and cell
specificity of eQTLs. To do this, we quantified the overlap between cis-eQTL SNPs and 526 genomic
features associated with functional cis-regulatory elements (CREs), including evolutionarily constrained
elements, CpG islands, open chromatin regions, chromatin marks, and binding sites for insulators and
other DNA associated regulatory proteins (see Table S5 for full list of data sets). We categorized regions
of open or active chromatin, and regions of transcription factor or DNA protein binding as active CREs,
and regions of repetitive, repressive, or heterochromatic chromatin domains as repressed CREs, to draw
a contrast between genomic regions where transcription factor binding is frequent and regions where it
is discouraged or unlikely. When data were available from multiple cell types and CREs were cell type
specific, we focused analyses on the cell type that most closely matches the eQTL discovery cell type. For
example, we focused analyses of LCL eQTL SNPs on 166 CRE data sets produced in LCLs (primarily
GM12878) and analyses of liver eQTLs on 150 CRE data produced in HepG2 cells, a well-characterized,
if imperfect, proxy for hepatocyte biology. We note that the quantification of eQTL SNP-CRE overlap
enrichments is inherently conservative, given that the boundaries of most genomically defined CRE types
are imprecise and that eQTL SNPs are typically tag SNPs, rather than the exact causal variants.
Consistent with the hypothesis that many eQTL SNPs exert their affect by modifying the biochemical
function of CREs, cis-eQTLs are known to be enriched for overlaps with several classes of CREs, includ-
ing DHS sites (Figure 3A), relative to the background distribution of tested cis-SNPs [50,51]. Moreover,
cis-eQTLs have been shown to be depleted within regions in which an insulator binding site lies between
the eQTL SNP and the target gene TSS (Figure 4G). We further extend these observations by demon-
strating that LCL eQTL SNPs are associated (p < 0.05, quantified by Equation (1)) with 135/166 LCL
derived CRE data sets, liver eQTL SNPs are associated with 79/150 HepG2 derived CRE data sets, and
cerebellum eQTL SNPs are associated with 1/1 cerebellum derived CRE data set (Figures S9-10). We
suspect that the decreased enrichment of liver eQTL SNPs within HepG2 CREs (relative to the enrich-
ment observed between LCL eQTLs and LCL CREs) may be due to both the increased number of eQTLs
identified in LCLs as well as the fact that HepG2 cells do not fully recapitulate the biology of primary
hepatocytes. Almost universally, eQTL SNPs are enriched within regions of active CREs (Figure 3; Ta-
bles S6-S8), while being depleted within repressed CREs (Figure 4, Figures S9-10, Tables S6-S8). For
example, we find that LCL eQTL SNPs are enriched within 134/141 active CREs while being depleted
within 18/23 repressed CREs (Fisher’s exact test p < 2.93× 10−14). Liver eQTL SNPs display a similar
enrichment within active CREs and depletion within repressed CREs (p < 4.02 × 10−10). Active CRE
classes significantly enriched for eQTL SNPs include FAIRE domains, H3K27Ac domains, methylated
DNA domains, and regions of H2A.Z, Pol II, and p300 enrichment (see Figure 3 for selected examples and
Tables S6-S8 for complete results). CRE classes significantly depleted for eQTL SNPs include H3K27me3
and H3K9me3 domains and regions with intervening insulators (see Figure 4 for selected examples and
Tables S6-S8 for complete results).
The frequency of eQTL SNP overlap with each class of CRE displays significant spatial structure
and is typically consistent with the known biology of the CRE (Figures 3-4, Figure S11). Although
substantial heterogeneity exists in the pattern of eQTL SNP enrichment across cis-regulatory element
types, we find that eQTL SNP overlap with TFBS, OCRs, and active chromatin marks is markedly
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depicts overlap with distinct CRE data sets: (A-C) DNAse hypersensitive sites, (D-F) p300 binding
sites, (G-I) chromHMM predicted active promoters. In each panel, SNPs are grouped into 25 equally
spaced bins within the 50kb upstream and downstream of the TSS and TES, and 10 bins between the
TSS and TES. Each bin is plotted along the x-axis. Bold lines depict the percentage, per bin, of SNPs
overlapping the CRE class, ribbons depict 95% confidence interval. Each column of panels depicts a
distinct SNP set contrast. (A,D,G) Observed eQTL SNPs (blue) and randomly drawn cis-linked SNPs
at expressed genes (red). (B,E,H) eQTL SNPs that replicate in Stranger LCL (log10BF ≥ 1) (green)
and SNPs that fail to replicate (purple). (C,F,I) CAP LCL eQTL SNP overlap with CREs derived from
the LCL line GM12878 (orange) and HepG2 cells (brown).
enriched immediately upstream of the TSS. For example, DHS sites are indicative of histone-depleted
open chromatin and are a classic feature of active regulatory elements [52]. We find that the frequency of
overlap between eQTL SNPs and DHS sites is greatest immediately adjacent to the TSS (Figure 3A-C),
confirming that regulatory SNPs are enriched at transcriptionally active promoters. While this trend also
exists in background SNPs, it is much more pronounced in eQTL SNPs (p < 2.2× 10−16).
In contrast, we find that eQTL SNP overlap with heterochromatin, repressive chromatin, or repetitive
regions is typically most highly depleted in the span immediately upstream of the TSS through the
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Figure 4. Negative regulatory element overlap is cell type specific and predicts eQTL
reproducibility. (A-I) CAP LCL eQTL SNP (FDR ≤ 5%) overlap with predicted cis-regulatory
elements. (A-C) eQTL SNP overlap with chromHMM predicted heterochromatin, (D-F) eQTL SNP
overlap with chromHMM predicted repressed chromatin, while (G-I) eQTL SNP-TSS pairs with an
intervening CTCF binding site. In each panel, SNPs are grouped into 25 equally spaced bins within the
50kb upstream and downstream of the TSS and TES, and 10 bins between the TSS and TES. Each bin
is plotted along the x-axis. Bold lines depict bin percentage, ribbons depict 95% confidence interval.
Each column of panels depicts a distinct SNP set contrast. (A,D,G) Observed eQTL SNPs (blue) and
randomly drawn cis-linked SNPs at expressed genes(red). (B,E,H) eQTL SNPs that replicate in
Stranger LCL (log10BF ≥ 1) (green) and SNPs that fail to replicate (purple). (C,F,I) CAP LCL eQTL
SNP overlap with CREs derived from the LCL line GM12878 (orange) and HepG2 cells (brown).
gene body (e.g., Figures 4A and D). Thus, eQTL SNPs are unlikely to be found within regions of
repressed chromatin or heterochromatin, presumably because CREs within such regions are inaccessible to
transcriptional regulators. Similarly, we find that intervening CTCF sites are most depleted immediately
upstream of the gene TSS; the decay of this depletion is nearly symmetrical about the TSS (Figure 4G).
The above mentioned spatial overlap patterns represent the most commonly observed patterns that we
observed (Figures 3-4); intriguing modifications to these patterns were observed for many elements tested
(e.g., chromHMM class transcription elongation, which is highest within the gene, Figure S11).
Secondary eQTL SNPs are themselves also associated with numerous CRE classes. For example,
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primary and secondary CAP LCL eQTL SNPs are associated (p < 0.05, quantified by Equation (3))
with 134/166 and 100/166 LCL CRE classes, respectively (Figure S9, Table S9). Interestingly, CTCF
insulator binding sites are significantly enriched between primary and secondary eQTL SNPs (Figure
S12; p < 1.95 × 10−11, quantified by Equation (4)). Independently associated primary and secondary
eQTL SNPs separated by less than 20kb are more than twice as likely to have an intervening insulator as
similarly spaced background cis-SNPs (55.7% versus 22.6%). We note that insulators are enriched between
alternative promoters in Drosophila melanogaster [53], supporting the notion that insulators frequently
demarcate CREs of the same gene, but, to our knowledge, this represents the first demonstration of
this phenomenon in humans. These observations, combined with the substantial replication rates of
non-primary eQTL SNPs (Figure S6), suggest that many of the SNPs identified in our scans for allelic
heterogeneity tag SNPs affecting the biochemical function of distinct CREs that independently regulate
transcription, rather than SNPs tagging the same causal regulatory variant.
Regulatory element overlap predicts eQTL reproducibility
We next investigated whether patterns of eQTL SNP-CRE overlap were associated with eQTL repro-
ducibility. Within cell type reproducibility of CAP LCL eQTL SNPs is significantly associated (p < 0.05,
quantified by Equation (2)) with SNP overlap with 20/164 LCL CRE data sets. Similarly, within cell
type reproducibility of liver eQTL SNPs is significantly associated with SNP overlap with 31/150 HepG2
CRE data sets. Furthermore, reproducible eQTLs are more likely to overlap active CRE classes, and are
less likely to overlap repressed CRE classes than are non-reproducible eQTLs (in LCLs: p < 0.029, in
liver: p < 0.0069; Figures 4B, 4E, 4H, and 5). For example, CAP LCL eQTL SNPs are enriched, rela-
tive to background SNPs, within H3K36me3 enriched regions, which typically mark active transcription
(p < 2.2×10−16). Moreover, CAP LCL eQTL SNPs that replicate in Stranger LCLs are significantly more
likely to overlap H3K36me3 enriched regions than are eQTL SNPs that fail to replicate (p < 5.18×10−5).
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Figure 5. Cell specificity of eQTL SNP-CRE overlap illustrated with DNAse
hypersensitivity data. Percentage (dots) and 95% confidence interval (lines) of (A) CAP LCL, (B)
UChicago liver, and (C) Harvard cerebellum eQTL SNPs overlapping DHS sites (y-axis) derived from
the LCL cell line GM12878 (red), the HepG2 cell line (blue), and the cerebellum (green).
Similarly, liver eQTL SNPs are enriched within FoxA1 binding sites more than would be expected
from the distribution of background cis-SNPs (p < 0.0011). Furthermore, within cell type reproducible
liver eQTL SNPs are more likely to be found within FoxA1 binding sites than are irreproducible eQTL
SNPs (p < 0.03). In summary, cis-eQTL SNPs are significantly enriched within active CREs and depleted
within repressive chromatin, and, moreover, these associations are more pronounced when contrasted with
externally replicating eQTLs. This suggests that irreproducible eQTL SNPs are often identifiable in the
absence of additional gene expression data for particular cell types of interest when CREs are available
for that cell type.
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eQTL-regulatory element overlap is frequently cell type specific
Previous investigations have suggested several plausible mechanisms underlying the cell type specificity
of eQTLs [18,24,27]. Cell type differences in expression of the gene of interest could modify the effect of
an underlying regulatory SNP or decrease the sensitivity of eQTL discovery. Similarly, cell type specific
differences in the expression of trans-acting regulators that bind to polymorphic TFBSs could generate
SNPs with cell type specific expression associations. Given the known cell type specificity of regulatory
protein binding sites and local chromatin environment [28,54,55], it is plausible that a SNP that disrupts
a TFBS would have different downstream effects if it were found within a region of open, active chromatin
as opposed to a region of repressed chromatin. Although the current resolution of CRE tag eQTL SNP
data sets make this hypothesis difficult to test directly for individual SNPs, we sought to quantify the
frequency, in aggregate, with which eQTL SNPs overlap CREs that differ between cell types using our
identified eQTLs and CRE data from the ENCODE project.
We assessed cell specific eQTL SNP-CRE overlap for LCL, liver, and cerebellum eQTLs by quantifying
the fraction of eQTL SNPs overlapping a CRE derived from the same cell type, relative to the fraction
overlapping a CRE derived from a second cell type. When the frequency of overlap between an eQTL SNP
set and the matched and unmatched cell type CREs are statistically significantly different, we consider
the overlap to be cell specific. LCL and liver eQTL SNPs were tested for overlap with 105 CRE data
sets available from both LCLs and HepG2 cells, while cerebellum eQTLs were tested for overlap with
a single pair of cerebellum and LCL CRE data sets. Consistent with a significant fraction of cell type
specific eQTLs, we find that eQTL SNP-CRE overlap is frequently cell specific (see Figures 3, 4 and 5,
for examples, Tables S6-S8 for full results). LCL and liver eQTL SNPs are significantly differentially
represented (McNemar’s test p < 0.05) in 97/105 and 86/105 CRE data types, respectively; moreover,
cerebellum eQTLs are over-represented in cerebellum derived DHS sites relative to LCL DHS sites (Table
S8). For example, 8.2% and 4.2% of CAP LCL eQTL SNPs overlap LCL and HepG2 derived chromHMM
strong enhancers, respectively (p < 2.89 × 10−52). Notably, the cannonical biochemical function of the
CRE class is predictive of the pattern of cell type specific eQTL-CRE overlap. eQTL SNPs are more
likely to overlap active CREs and less likely to overlap repressed CREs derived from the same cell type
as the eQTL discovery data (repeated measures logistic regression p < 4.63× 10−3; Tables S6-S8).
Interestingly, while eQTL SNPs are typically more highly enriched within TFBS derived from the
same cell type as opposed to the unmatched cell type, several of the exceptional CRE classes seem
worthy of note. Both LCL and liver eQTL SNPs are significantly more likely to overlap IRF3 binding
sites derived from LCLs, as well as RXRA binding sites derived from HepG2, consistent with the known
biochemical function of these factors in the immune system and liver, respectively. We also investigated
the relative locations of insulators with respect to cell type. We found that the proportion of eQTL SNP
- TSS pairs with intervening insulators is remarkably consistent across cell types, indicating substantially
less cell type specificity in insulator locations than in open, active, or repressed chromatin states (Figure
4I, Tables S6-S8). Analysis of the cell type specificity of LCL and HepG2 CTCF binding site overlap
further supports this notion; ≈ 80% of active CTCF binding sites overlap between LCLs and HepG2
cells, which is substantially greater than the overlap observed for DHS sites, FAIRE sites, or regions of
active chromatin marks (Figure S13). Further supporting this observation, we note that a similar paucity
of CTCF binding site cell type specificity exists in Drosophila melanogaster [53].
Genetic architecture of cell type specific eQTLs
Consistent with the hypothesis that the CRE landscape is a major determinant of eQTL specificity,
eQTL SNPs that overlap cell type specific CREs are more significantly likely to be cell type specific than
are eQTL SNPs that overlap shared CREs (Fisher’s exact test p < 0.05) for 44/105, 44/105, and 1/1
CRE data sets in LCLs, liver, and cerebellum, respectively (Tables S6-S8). For example, LCL eQTLs
are significantly more likely to be cell type specific (i.e., replicate in an independent cohort of LCLs but
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fail to replicate in the liver) when they overlap an LCL-derived p300 binding site, but fail to overlap
a HepG2-derived p300 binding site (p < 0.0027). Similarly, liver-derived eQTLs are significantly more
likely to be cell type specific if they overlap a HepG2-derived open chromatin region but fail to overlap
an LCL- derived open chromatin region (p < 3.04× 10−4). To illustrate a specific example, we examined
the pattern of cell specific eQTL SNP- CRE overlap at the SORT1 locus, a well characterized myocardial
infarction risk locus (Figure 6) [15]. Consistent with previous obeservations, we find a liver specific eQTL
association ≈ 40 kb downstream of the SORT1 gene. Consistent with this specificity, we also observe
that this eQTL SNP overlaps a cluster of predicted enhancers that are present in HepG2 cells but not
LCLs.
Given the association between cell type specific eQTLs and cell type specific cis-regulatory elements,
we sought to test our ability to use CRE data in conjunction with genomic location information to
predict the cell type specificity of eQTLs. We trained a random forest classifier on a large set (n = 526)
of features, including SNP position, effect size, cell type specific CRE overlap, and non-cell type specific
genomic elements (see Table S5 for full list) to predict whether each eQTL SNP association would replicate
in a second study (i.e., binary class). We validated the classifier with 10-fold cross validation. We found
that the classifier could accurately predict within cell type eQTL replication, between cell type eQTL
replication, and cell type specific eQTL replication (Figure 7, Table 3). For example, the area under
the ROC curves (AUC ) for within LCL replication, between LCL and liver replication, and LCL specific
replication were 0.79, 0.73, and 0.67, respectively. Therefore, given a broad collection of chromatin state
and regulatory factor binding site data sets, such as is available for a large number of cell types in the
ENCODE project database, it is possible to predict with substantial accuracy whether a given eQTL
association exists in a different, specific cell type, in the absence of any gene expression data from the
second cell type.
Table 3. Accuracy of random forest classifier predictions.
Prediction AUC Accuracy κ
CAP LCL ∈ Stranger LCL 0.79 0.74 0.44
CAP LCL ∈ Merck liver 0.73 0.82 0.16
CAP LCL ∈ (Stranger LCL \ Merck liver) 0.67 0.71 0.18
UChicago liver ∈ Merck liver 0.74 0.70 0.39
UChicago liver ∈ Stranger LCL 0.77 0.73 0.29
UChicago liver ∈ (Merck liver \ Stranger LCL) 0.71 0.66 0.30
Harvard cerebellum ∈ Myers brain 0.71 0.83 0.15
Harvard cerebellum ∈ Stranger LCL 0.77 0.81 0.23
Harvard cerebellum ∈ (Myers brain \ Stranger LCL) 0.68 0.60 0.18
We further quantified the contribution of each feature to prediction accuracy (see Methods). Across
all training sets, we found that eQTL discovery significance, SNP to TSS distance, and gene expression
level contribute substantially to prediction accuracy (Table S10). Consistent with the relative cell type
specificity of insulators and chromatin marks discussed above, cis-regulatory elements with different func-
tionality vary considerably in the degree to which they are useful in predicting within or between cell
type replication. For example, we find that the presence of intervening insulators contributes substan-
tially to within cell type predictions but less so for between cell type predictions, as might be expected
considering its function is less cell type specific. In contrast, cell type specific differences in the chromatin
modification state of the eQTL SNP contribute substantially to the accuracy of predictions of between
cell type eQTL replication.
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Figure 6. SORT1 eQTL suggests mechanisms underlying cell specificity of eQTLs.
Associations between (A) UChicago liver and (B) CAP LCL SORT1 expression and cis-linked SNPs
(left y-axis; log10BF ), plotted as points by SNP genomic coordinates (x-axis). Blue line overlaying the
manhattan plot is the estimate of the local recombination rate (right y-axis; cM/Mb). Points are
colored by level of LD (see legend below) with the reference SNP (purple diamond). Below each
manhattan plot are boxes depicting the location of chromHMM predicted promoters (red), enhancers
(orange), and insulators (blue). Below CRE predictions are RefSeq gene models.
This preliminary classifier serves a three-fold purpose. First, quantifying the importance of each
feature for prediction accuracy enables the identification of specific CREs involved in determining the
cell type specificity of regulatory SNPs. Second, it facilitates follow-up analyses of SNPs of interest by
predicting the cell types in which they may be functional and the specific CREs that may determine the
type of biochemical function they exert. Finally, it acts as a proof-of-concept for further refinements and
generalizations for prediction of cell type specificity for specific eQTLs.
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Figure 7. Data integration predicts cell type specificity of eQTLs. ROC curves depicting the
predictive ability of a random forest classifier to predict within cell type reproducibility (red), between
cell type reproducibility (blue), and within cell type specific reproducibility (green). Predictions plotted
separately for (A) LCL/LCL/Liver, (B)Liver/Liver/LCL, and (C) Brain/Brain/LCL . The classifier was
trained on a diverse collection of CREs (see methods and supplement for complete data set description).
True positive rates (y-axis) and false positive rates (x-axis) were quantified by ten fold cross validation.
Discussion
The integrative analyses presented here provide new insights into the patterns of cis-eQTL replication
within and between cell types, while controlling for biological and technical variation. Our predictive
models allow us to make preliminary estimates of the likelihood of eQTL replication between cell types of
interest based on the location of the eQTL, the cell types in question, known and predicted CREs, and gene
function. Several notable results emerge from our analyses. We find that within cell type eQTL replication
is relatively stable across different comparisons and uniformly greater than between cell type eQTL
replication, indicating that a meaningful fraction of eQTLs are cell type specific. A substantial fraction
of eQTL loci exhibit allelic heterogeneity (i.e., multiple genetic variants independently associated with
an expression phenotype). We demonstrate that non-primary eQTLs replicate at substantial frequencies,
and are more likely to be promoter distal and cell type specific.
Importantly, we demonstrate that eQTLs are more likely to overlap active CREs and less likely to
overlap repressive CREs when they are ascertained from the same cell type versus different cell types. Cis-
eQTL SNPs overlapping most classes of activating cis-regulatory elements are significantly more likely to
replicate in independent studies. Conversely, eQTL SNPs that overlap repetitive or repressed chromatin
states and eQTL SNP-gene pairs that are intersected by insulators are significantly less reproducible. Cis-
eQTL SNP-CRE overlap is also significantly more predictive of eQTL reproducibility when the CRE data
are derived from the same cell type as the gene expression data. Furthermore, eQTL SNPs that overlap cell
type specific CREs are significantly enriched for cell type specific eQTLs, suggesting specific regulatory
mechanisms for those cell type specific eQTL associations. The observed relationship between eQTL
SNP reproducibility and CRE overlap led us to test the hypothesis that independently derived CRE data
could be used to predict the cell type specificity of eQTLs in the absence of additional gene expression or
genotype data. While we see room for substantial improvement, we believe that the successful validation
of this hypothesis with a random forest classifier will enable improved interpretation of genome-wide
association study results.
Because we remapped and clustered expression probes to create uniformity across the different gene
expression array platforms, we actually created multiple gene expression values for each single gene.
Although we combined the eQTL results across the different gene expression clusters for each gene after
the analysis, in future work we will identify eQTLs jointly across the gene probe clusters. We performed
this analysis in a genome-wide manner because the eQTLs we identify individually likely only tag the
specific causal variant, but in aggregate are enriched within specific regulatory elements classes. This
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genome-wide enrichment points to biological mechanisms determining function and cell type specificity
of SNPs, and enables the predictive models to perform well. One caveat to this interpretation is that,
of the CREs that co-localize with eQTL SNPs in a cell type specific manner, some proportion of those
CREs permissively allow the SNP to be functional (e.g., DHS sites are where transcription factors are
able to bind to DNA), and some proportion will be the CREs through which the SNP influences genetic
regulation (e.g., interrupting binding of a specific transcription factor). While we do not currently examine
the directionality of these causal interactions, this is an area of current research.
After a GWAS is performed, it is now common practice to search eQTL databases to determine
whether SNPs of interest are eQTLs for the cell type relevant to the study phenotype. When the SNPs
are not known eQTLs in the cell type of interest, typically the line of reasoning is dropped; however, it is
possible that the specific cell type was not tested, that the relevant SNP-gene pair was not interrogated,
or that the sample size was too small for a cell type specific study to substantiate the SNP as an eQTL.
Instead, if the researcher finds that the SNP is an eQTL in an alternative cell type, our classifier can
be applied to determine the likelihood of the SNP being an eQTL in the cell type of interest if there
are CRE data available for the relevant (or related) cell type. Furthermore, the genomic location can be
scrutinized relative to known CREs to identify specific CRE types that may explain the mechanism by
which gene transcription and downstream phenotype are regulated. Conversely, given those same GWAS
hits, using these predictions one might be able to identify the physiologically relevant cell type based on
overlap with (predicted or known) cell specific eQTLs.
Materials and Methods
Genotype preparation
Genotype data were downloaded from public databases or individual investigators as summarized in Table
1. Genotype and quality control filtering was performed with plink [56]. Individuals with a call rate of
less than 90% were removed. SNPs with a call rate of less than 90% were classified as missing and later
imputed. SNPs deviating from HWE were removed (p < 1× 10−4).
Merck liver study genotypes were previously imputed by MACH [57]; we extracted from the full set
of SNPs only those that were > 90% unimputed (and we removed all of the imputed genotypes from
individuals in the non-imputed SNPs) to represent the original genotyping data. This set we filtered
using identical criteria as above.
The HapMap phase 2 individuals fully sequenced genotypes were downloaded from the Impute2 web-
site [58]; we matched the genotypes to individuals by comparing individual SNPs to genotypes from
the indexed individuals. We filtered these genotypes as above. We removed ungenotyped individuals
in the Harvard study, leaving us with 540 individuals with cerebellum tissue data, 678 individuals with
prefrontal cortex tissue data, and 463 individuals with visual cortex tissue data.
Genotype imputation
Genotypes were imputed using BIMBAM [34]. We imputed genotypes up to the HapMap phase 2 CEPH
3.8×106 SNP set. BIMBAM removes SNPs with a minor allele frequency (MAF) less than 0.01 or missing
SNPs by default. For the studies with Caucasian only participants, we used only the 60 unrelated CEPH
individuals for imputation. For the UChicago liver study, which has 27 African American individuals (of
206 subjects total), we used both the CEPH and the 60 unrelated YRI individuals as a reference set. For
the Stranger LCL study on a subset of HapMap phase 2 individuals, we used the CEPH, YRI, and the
90 unrelated JPT and CHB individuals’ genotypes and did not impute. Mean values for the imputed
genotypes were used for association and other downstream analyses [39].
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Gene expression preparation, normalization, and processing
For each expression array platform, probe sequences were aligned to the human reference genome (hg18)
and the RefSeq transcript set. Probes with only one genomic alignment with ≥ 90% identity to the
reference genome, over the full length of the probe, were considered to be uniquely aligned. Probes that
failed to align to the genome but did have at least one alignment with at least 90% identity to a RefSeq
transcript were further considered to be adequately aligned. All other probes were removed from further
analyses. Based on genomic alignment coordinates and RefSeq gene annotations, each aligned probe was
assigned to a RefSeq gene. We further searched the genomic locations of each probe alignment for the
presence of common polymorphisms, as defined by dbSNP131 and the One Thousand Genomes Project
(8/4/2010 release [59]).
Where appropriate, we defined a lower expression level boundary, above which we considered a gene
to be expressed. Genes falling below the expression threshold were removed from further analyses. Low
expression thresholds were defined either on the basis of negative control probes, exogenous RNA spike
in probes, or the observed relationship between probe mean expression and variance.
Gene expression data from each study were prepared independently as follows. Poorly extracted, non-
uniform, outlier, or other flagged features were treated as missing data. Where appropriate, background
signal intensities were subtracted. Negative adjusted intensities were set to one half the minimum positive
value on the array. Background corrected intensities were log2 transformed. Missing data were imputed
using the k-nearest neighbors algorithm (k = 10), as implemented in the R package impute [60]. Each
array was quantile transformed to the overall average empirical distribution across all arrays. Across all
arrays within a study, each probe’s expression values were transformed to the quantiles of the standard
normal distribution (or quantile normalized). Transformation to standard normal avoids potential prob-
lems due to outliers or other deviations from normality in later association tests [36]. For gene expression
data derived from individuals with multiple ancestries (Stranger LCL, UChicago liver), we quantile nor-
malized within each population separately to control for population-specific expression levels [61]. We
controlled for known and unknown sources of non-genetic variation by correcting these data using their
principle components (PCs), identified using the R function pca from the R package pcaMethods [37,38].
We did not explicitly control for known covariates (e.g., age or sex) to enable cross-study comparison, and
instead assumed that the relevant covariates will be incorporated in the PCs [38]. We jointly controlled
for the effect of all PCs by again taking the residuals from a linear model with these PCs as covariates.
We considered PCs until the difference in the variance explained by an additional PC was less than
0.00025% (Table S1). Finally, we quantile normalized these residuals within each probe and used these
normalized data in our subsequent analyses.
For genes with multiple probes on a single array, we used the R package mclust [62] to cluster the p
probes × n samples matrix of expression levels. We allowed min(4, p) clusters per gene. Within each probe
cluster, we used the per individual, PC corrected mean of the different probes as a proxy for the gene
expression level for that collection of probes. Each probe cluster was modeled downstream independently,
under the assumption that uncorrelated probe sets represent either independent transcript isoforms or
poorly performing probes.
eQTL mapping
We used Bayesian regression, as implemented in BIMBAM [33, 39] to quantify the association between
each SNP and residual gene expression data for each gene across each sample from each study. We used
default parameters, which average over different plausible effect sizes for additive and dominant models.
We used the mean imputed genotype for all studies except Stranger LCLs, in which we used assayed
genotypes for each individual because the individuals did not require imputation.
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Summarizing eQTLs
We identified the SNP with the largest log10BF for each gene, and also identified the cis-SNP with the
largest log10BF in each LD block around a gene. We defined LD blocks using the HapMap recombination
rates [63] in which each SNP interval with ≥ 10 cM/Mb defines the boundaries of an LD block. For each
of these associations, we note the chromosome and location of the gene and SNP, major and minor allele
of the SNP, the LD block index, the MAF of the SNP in the sample population, the r2 value of the
fit of the linear model between the imputed values for the SNP and the rounded values of the SNP,
the magnitude and direction of the association (β) and the r2 value of the fit of the linear model, the
number of exons and the average length of the gene exons, number of probes corresponding to the probe
cluster, mean gene expression value for those probes, and the log10BF for this association. We determine
the maximum MAF for all SNPs overlapping expression array probe alignment coordinates using One
Thousand Genomes Project data and dbSNP131. For all downstream comparisons between studies, we
consider only expressed gene-SNP pairs in common between the two studies.
Evaluating FDR by permutation
To evaluate the FDR for each study, we permuted the sample indices on the gene expression data iden-
tically across genes within each study, and ran association mapping on these permuted data. Then, for
each cutoff log10BF , we conservatively computed FDR by the number of associations identified in the
original data at that cutoff divided by the number of associations identified in the permuted data at that
cutoff (Table S11). We performed a single permutation for each study because of the resources required
to run a single complete permuted association test. Unless otherwise noted, eQTL results in the text
refer to associations significant at FDR ≤ 5%.
Multivariate analysis
Given the computational requirements of performing ≈ 20, 000 conditional QTL scans in eleven studies,
we implemented a two step approach to identify independently associated SNPs at each gene. For each
gene probe cluster, we identified the most highly associated SNP in each LD block within 1Mb of the
gene’s transcription start site (TSS) or transcription end site (TES). We subsequently recomputed the
BF of each SNP association by Bayesian multivariate regression to quantify the conditional independence
of the effects of the associated SNPs [64]. Finally we took the union of the identified SNPs from all probe
clusters for a single gene; when this set had more than one SNP below the appropriate FDR ≤ 5% cutoff,
the gene is said to exhibit allelic heterogeneity.
We compared this approach to forward stepwise regression for a subset of CAP LCL genes with sig-
nificant allelic heterogeneity (FDR ≤ 5%). We implemented, in R, a custom forward stepwise regression
with all SNPs within 1Mb of a gene’s TSS and TES to identify the set of independently associated SNPs.
In particular, starting from the model with a gene probe cluster as the response variable and no covariates,
we included a SNP in the model when it most improved the Bayesian Information Criterion (BIC) of the
fitted model. The BIC is a criterion for model selection that takes into account both the likelihood of the
model and the number of parameters (here, eQTL SNPs), so as to avoid excessive parameters that may
result in overfitting. We continued to identify a single SNP that most improves the BIC and included
that SNP in the model until a SNP resulted in a non-improvement of the BIC, when we stopped. As in
the LD-based method, we took the union of the identified SNPs from all probe clusters for a single gene.
Although forward selection is not exhaustive, it is tractable, and these results represent a more complete
(but still conservative) estimate of the allelic heterogeneity for a particular gene relative to our method
of identification (for full results comparison, see Table S3). In particular, we note that this method is an
approximation in the presence of interactions [65], but we consider this case to be beyond the scope of
this analysis.
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Analysis of Gene Ontology annotation enrichment
We performed Gene Ontology (GO) [47] enrichment analyses using DAVID software [20]. We considered
GO Biological Process ontology, Molecular Function ontology, and KEGG pathway [66] enrichment terms
with FDR ≤ 20% (Table S2). We considered CAP LCL, UChicago liver, and Harvard cerebellum as
eQTL discovery data sets, and looked for enrichment among AH genes in these data, and also looked for
enrichment among genes that did and did not replicate within cell type and between cell type studies as
above.
Replication quantification
A SNP-gene association was considered ‘replicated’ if the log10BF ≥ 1.0 in the target study of the same
SNP-gene pair with a log10BF less than the cutoff for FDR ≤ 5% for that tier in the discovery data set.
Only SNP-gene pairs that were observed in a given replication cohort were considered when calculating
the replication frequency in that study. In other words, if a SNP failed quality control or if a gene was not
represented on a particular gene expression microarray platform, the SNP-gene pair was not considered
when calculating replication.
Comparison between eQTLs and functional genomic data sets
When available, CRE data from the CEU HapMap LCL line GM12878, the hepatocellular carcinoma
HepG2 cell line, and primary cerebellum tissue were used to represent LCLs, liver, and cerebellum re-
spectively. These data sets (fully listed in Table S5) were all downloaded directly from the ENCODE data
coordination center at UCSC. Cell type independent data sets were also used, including CpG islands [67],
GERP evolutionary constrained elements [68], clustered DNAse hypersensitive sites, and clustered tran-
scription factor binding sites. A second chromatin structure segmentation (Segway [69]) data set, derived
from the integration of K562 data sets, was also included in the regulatory element feature set. When
available, precomputed ‘peak calls’ were used. If more than one replicate (i.e., peak calls generated in
the same lab using the same antibody), was available, peak calls were merged by taking the union of all
elements.
Given that a putative eQTL SNP does not necessarily represent the causal genetic variant, but rather
is a ‘tag’ for the causal variant in substantial linkage disequilibrium, we classified a SNP as overlapping a
given genomic element if it was either contained within the element or found within 500bp of the element
boundary. CTCF sites were classified as eQTL interrupting if the midpoint of the CTCF binding site
was between the eQTL SNP and the TSS of the associated gene.
To test if eQTL SNPs are enriched within each class of putative cis-regulatory element, we first
modeled the background distribution of cis-linked SNPs as follows. All CEU HapMap phase 2 SNPs that
lie within 1Mb of a RefSeq gene model TSS or TES, or lie within a RefSeq gene model were included.
Each such SNP that was cis-linked to more than one RefSeq gene model was randomly assigned to one
such gene. As with the eQTL SNP set, the background SNP set was tested for overlap with any element
in each genomic feature class. For each eQTL or background SNP (i), we modeled the probability of
cis-regulatory element overlap (pi) by logistic regression:
ln
(
pi
1− pi
)
= β0 + β1Di + β2Gi + β3Ii + i. (1)
In this equation, we controlled for the effects of SNP position (Di = log10 |SNPi − TSSi|) and the
expression level of the associated gene (Gi), in order to quantify the difference in overlap frequency
between observed eQTL SNPs and those drawn from the background SNP distribution (denoted by the
indicator variable Ii).
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Similarly, for each eQTL SNP (i), we model the effect of cis-regulatory element overlap (Ci) on the
probability of within cell type replication (pi) by logistic regression:
ln
(
pi
1− pi
)
= β0 + β1Mi + β2Ti + β3Di + β4Ci + i. (2)
In this equation, we controlled for the effects of SNP position and the significance of the eQTL association
(Mi = log10BF , as assessed by Bayesian multivariate regression) and the ‘tier’ of the associated SNP
(Ti), in order to quantify the enrichment of within cell type replicating eQTLs in cis-regulatory elements.
We tested for an enrichment of second tier SNPs within CRE data sets, relative to the expectation
from the background distribution of cis-linked SNPs, by modeling, for each SNP (i), the probability of
cis-regulatory element overlap (pi) by logistic regression:
ln
(
pi
1− pi
)
= β0 + β1Di + β2Gi + β3Ti + i. (3)
where we quantify the difference in overlap frequency between background SNPs, primary tier SNPs,
and secondary tier SNPs with the indicator variable Ti. Enrichment of secondary SNPs, relative to
background, was quantified by testing for the significance of the difference between the β3 estimates.
To test for an enrichment of CTCF sites between SNPs independently associated with the same gene
expression trait (i.e., SNPs tagging the allelic heterogeneity at a given locus), we used the background
distribution of cis-linked SNPs as defined above; however, for each RefSeq gene, two cis-linked SNPs were
selected at random. This collection of background SNP pairs was contrasted with the first and second
most highly associated SNPs at all genes for which the secondary SNP was significant at a FDR ≤ 5%
threshold. For each SNP pair (j), we modeled the probability of the presence of an intervening insulator
(pj) by logistic regression:
ln
(
pj
1− pj
)
= β0 + β1DSj + β2DTj + β3HSj + β4TSj + β5Ij + j . (4)
In this equation, we controlled for the inter-SNP distance (DSj), SNP pair position relative to the gene
TSS (DTj = mink(|SNPj,k − TSSj,k|), in which k indexes each SNP in the pair), the presence of an
intervening recombination hotspot (HSj), and the presence of an intervening TSS (TSj), in order to
quantify the difference in insulator frequency between observed eQTL SNP pairs and those drawn from
the background SNP distribution (denoted by the indicator variable Ij).
Predicting replicating eQTLs with random forests
We built a classifier to predict within cell type, between cell type, and cell type specific replication using
random forests [70]. A random forest is an ensemble classifier that uses the mode of predictions from a
large number of decision trees. For each pair of comparisons, we can train a random forest classifier to
predict the binary replication outcome given a set of features about the genomic location of the eQTL
and the CREs for the corresponding cell types (see Table S5 for complete set). We found this classifier
worked well in this scenario because it is capable of capturing interactions within the features. We used
the random forest classifier and computed variable importance using the R randomForest package [71].
We performed 10-fold cross validation to compute generalization error. We used the R package ROCR [72]
to build the ROC curves and compute the AUC.
Additional statistical analyses
Unless otherwise noted, 2 × 2 tests of categorical data were quantified by Fisher’s exact test. Tests of
paired interval data were quantified by Wilcoxon’s rank sum test. 2× 2 tests of paired categorical data
were quantified by McNemar’s test.
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